Koers Infinity Pharmaceuticals, Inc.
Aandelen
INFI.Q
US45665G3039
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | 0,00% | 0,00% | -99,96% |
Omzet 2021 | 1,86 mln. 1,74 mln. | Omzet 2022 | 2,59 mln. 2,42 mln. | Marktkapitalisatie | 49,59 mln. 46,33 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -45 mln. -42,05 mln. | Nettowinst (verlies) 2022 | -44 mln. -41,11 mln. | EV/omzet 2021 | 91,8 x |
Nettoliquiditeiten 2021 | 29,67 mln. 27,72 mln. | Nettoschuld 2022 | 11,04 mln. 10,31 mln. | EV/omzet 2022 | 23,4 x |
K/w-verhouding 2021 |
-4,25
x | K/w-verhouding 2022 |
-1,11
x | Werknemers | 30 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 97,27% |
3 maanden | -99,50% | ||
6 maanden | -99,98% | ||
Lopend jaar | -99,96% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Seth Tasker
CEO | Chief Executive Officer | 45 | 01-03-08 |
Jennifer Roberts
PRN | Corporate Officer/Principal | - | 01-10-17 |
Melissa Hackel
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Evnin
BRD | Director/Board Member | 83 | 01-09-06 |
Norman Selby
BRD | Director/Board Member | 71 | 12-03-12 |
David W. Beier
BRD | Director/Board Member | 75 | 01-04-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 0,000001 | 0,00% | 100 |
19-04-24 | 0,000001 | -99,00% | 141 |
slotkoers OTC Markets, 22 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-99,96% | 90 | |
+3,13% | 42,11 mld. | |
+48,83% | 40,08 mld. | |
+8,49% | 40 mld. | |
-10,82% | 26,87 mld. | |
+8,26% | 24,58 mld. | |
-23,69% | 18,44 mld. | |
+1,58% | 11,94 mld. | |
+32,83% | 11,66 mld. | |
+6,63% | 11,01 mld. |